|
ARHGAP31 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.97010000430242E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.42210004567312E-09 |
| Normal-vs-Stage2 |
1.000750E-03 |
| Normal-vs-Stage3 |
8.30509999660833E-08 |
| Normal-vs-Stage4 |
3.32530000002329E-06 |
| Stage1-vs-Stage2 |
3.272400E-01 |
| Stage1-vs-Stage3 |
7.829000E-01 |
| Stage1-vs-Stage4 |
4.037400E-01 |
| Stage2-vs-Stage3 |
1.915600E-01 |
| Stage2-vs-Stage4 |
9.758500E-02 |
| Stage3-vs-Stage4 |
3.302200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.22240001349172E-09 |
| Normal-vs-AfricanAmerican |
8.018400E-04 |
| Normal-vs-Asian |
5.618300E-02 |
| Caucasian-vs-AfricanAmerican |
8.451500E-02 |
| Caucasian-vs-Asian |
3.840600E-01 |
| AfricanAmerican-vs-Asian |
9.183800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55659995793434E-09 |
| Normal-vs-Female |
6.716300E-03 |
| Male-vs-Female |
9.124900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.226920E-04 |
| Normal-vs-Extreme_Weight |
2.56499999018445E-09 |
| Normal-vs-Obese |
1.1090999999519E-06 |
| Normal-vs-Extreme_Obese |
1.364400E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.116200E-01 |
| Normal_Weight-vs-Obese |
8.589000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.748200E-01 |
| Extreme_Weight-vs-Obese |
1.544760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.944600E-01 |
| Obese-vs-Extreme_Obese |
4.966800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.75069999999567E-05 |
| Normal-vs-Age(41-60Yrs) |
8.55599999960432E-07 |
| Normal-vs-Age(61-80Yrs) |
2.90199999586349E-08 |
| Normal-vs-Age(81-100Yrs) |
9.54779999999822E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.078800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.647000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.752000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.954800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.751000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.605800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.61830000300745E-08 |
| Normal-VS-Type2 PRCC |
3.63780000012248E-07 |
| Normal-VS-KIRP CIMP |
1.011160E-04 |
| Normal-VS-Unclassified PRCC |
1.109770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.882200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.359400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.028400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.791200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.772200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.940300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.00859999971637E-07 |
| Normal-vs-N1 |
8.16460000052643E-07 |
| Normal-vs-N2 |
8.211600E-04 |
| N0-vs-N1 |
9.908000E-01 |
| N0-vs-N2 |
5.543200E-01 |
| N1-vs-N2 |
3.952800E-01 |
|
|
